Skip to content
Research Article Open access CC BY 4.0

Febrile Episodes during Chemotherapy Induced Neutropenia in Children with Acute Lymphoblastic Leukemia at Children Hospital –Benghazi 2013-2014

Salima M. M. Alzehawi, Amina Beayou, Najat B. Elgazal, Fawzia S. Khalifa, Salimah S. Alabeedi, Mohamed M. Alferjani

Asian Journal of Pediatric Research · pp. 25–34 · Published 20 May 2022

10.9734/ajpr/2022/v8i430253

Abstract

Patients undergoing chemotherapy are vulnerable to infection because of immunosuppression and prolonged hospitalizations. Chemotherapy drugs affect neutrophil production through myelosuppression (1) and low inflammatory response so that fever maybe the manifestation of infection (2). The purpose of this study was to analyze febrile neutropenic episodes associated with infections in the 1st three phases of acute lymphoblastic leukemia (ALL) treatment, document the risk factors affecting morbidity, mortality, treatment and the outcome of treatment. The study was a cross-sectional hospital-based descriptive survey in the Hematology-Oncology Unit at Children’s Hospital. It included all cases of (ALL) who were diagnosed within two years and treated with the Berlin Frankfurt Munich (BFM) protocol who developed fever during a neutropenic period. Data was recorded as gender, age, residence, nationality, number of episodes per patient, treatment phase, admission duration, length of stay (LOS) per episode, symptoms, physical examination and severity of fever. Investigations, the antibiotic used and the outcome were also recorded. A total 27children, males accounting for 63%, 67<5 were included in the study. Febrile neutropenic episodes ranged 1–12. Their peak was in January. 40% were in phase II. LOS range 2-35 days. Fever showed a median of 38.8 °C, higher in phase II and III. Admission and therapy phases were longer in children ˂ 2 years old and in males. The neutrophil median was 270/mm3. Stomatitis was seen in70% of episodes, gastroenteritis in 65%, fever of unknown origin (FUO) in 16%and pneumonias in 15%. 20/23 bacterial infections were Gram-negative. 40% of episodes required a change of antibiotics. The mortality rate was 22%.

Acute lymphoblastic leukemia neutropenia fever Children’s Benghazi Libya

References (18)

  1. 1 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer [DOI]
  2. 2 Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia [DOI]
  3. 3 Changing Epidemiology of Infections in Patients with Neutropenia and Cancer: Emphasis on Gram-Positive and Resistant Bacteria [DOI]
  4. 4 Randomized, Dose-Escalation Study of SD/01 Compared With Daily Filgrastim in Patients Receiving Chemotherapy [DOI]
  5. 5 Prospective Evaluation of a Model of Prediction of Invasive Bacterial Infection Risk among Children with Cancer, Fever, and Neutropenia [DOI]
  6. 6 Bloodstream infections in cancer patients with febrile neutropenia [DOI]
  7. 7 Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment [DOI]
  8. 8 Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres [DOI]
  9. 9 Fever in the Pediatric and Young Adult Patient with Cancer [DOI]
  10. 10 Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia [DOI]
  11. 11 Risk-adapted strategy for the management of febrile neutropenia in cancer patients [DOI]
  12. 12 Evaluation of Six Risk Factors for the Development of Bacteremia in Children with Cancer and Febrile Neutropenia [DOI]
  13. 13 Antibacterial Prophylaxis in Patients with Cancer and Neutropenia [DOI]
  14. 14 The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies [DOI]
  15. 15 The Changing Epidemiology of Infections at Cancer Hospitals [DOI]
  16. 16 Prevention of Infections in the Neutropenic Patient [DOI]
  17. 17 Treatment of gram-positive septicemia in cancer patients [DOI]
  18. 18 Progress in the Treatment of Childhood Leukaemias [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

37

Page views

0

PDF downloads

5

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.